|Dr. Miroslav Reljanovic||Founder & Exec. Chairman||151.49k||N/A||1959|
|Mr. Richard T. Barfield||CFO & Exec. Director||N/A||N/A||1958|
|Mr. Lewis Cameron||Chief Operating Officer||N/A||N/A||1964|
|Ms. Sanja Juric||Gen. Counsel & Company Sec.||N/A||N/A||N/A|
|Dr. Shazia Rahman||Head of HR & Resourcing||N/A||N/A||N/A|
Ergomed plc provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom and Rest of Europe, the Middle East, Africa, North America, Asia, and Australia. The company offers clinical development, trial management, and pharmacovigilance services for pharmaceutical and generics companies, as well as small and mid-sized drug development companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, neurology, and CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.
Ergomed plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.